Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

By R. Yancik, M. Wesley, L. Ries, R. Havlik, B. Edwards, J. W. Yates. Journal of the American Medical Association (JAMA), 2001

887 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/93668f7fe4ff9d3ac18dd81425728391c4fdde8b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. M. Hewitt
2. M. Hung
3. Julia H. Rowland
4. G. Hortobagyi

Citations in the corpus

• Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. (2002, result): “Results from this study are compatible with those from studies that have reported that Medicare beneficiaries frequently fail to receive necessary care in compliance with practice guidelines(21,22) and that individuals of greater age and with greater comorbidity may be particularly susceptible to me”
• Future of cancer incidence in the United States: burdens upon an aging, changing nation. (2009, background): “Since chronological age is a poor descriptor of functional age, future studies in geriatric populations should explore factors other than chronological age, such as comorbidity, functional and nutritional status, cognitive functioning, and social support.(28) Such studies could ultimately lead to ev”
• Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study (2011, background): “Research has shown that other preexisting chronic conditions, or comorbidities, also have a significant effect on the overall survival of breast cancer patients [5-7].”
• Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. (2009, background): “This is consistent with the known worse outcomes of diabetic versus nondiabetic patients with breast cancer.(6-8) In addition, although the pCR rate in the metformin group was threefold that in the nonmetformin group, there was no significant difference in the RFS or OS between these two groups.”
• Cancer survivors in the United States: age, health, and disability. (2003, background): “Assessing levels of disability that are associated with cancer among cancer survivors is challenging because of the existence of higher levels of comorbidity at older ages (3,33,34).”